United Therapeutics Proxy Statement Filed
Ticker: UTHR · Form: DEF 14A · Filed: Apr 29, 2025 · CIK: 1082554
| Field | Detail |
|---|---|
| Company | United Therapeutics Corp (UTHR) |
| Form Type | DEF 14A |
| Filed Date | Apr 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
Related Tickers: UTHR
TL;DR
UTHR proxy out: exec pay, board details, and 5 years of financials. Vote wisely.
AI Summary
United Therapeutics Corp filed its definitive proxy statement on April 29, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation, board member information, and other corporate governance matters. Key financial data for the fiscal years 2020 through 2024 is included, with specific tables related to equity awards and pension values for the 2024 fiscal year.
Why It Matters
This filing provides shareholders with crucial information regarding executive compensation and corporate governance, enabling informed voting decisions on proposals presented at the upcoming annual meeting.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) providing information to shareholders and does not inherently introduce new risks.
Key Numbers
- 2020-2024 — Fiscal Years Reported (Includes financial data and compensation details for these years.)
Key Players & Entities
- UNITED THERAPEUTICS Corp (company) — Filer
- 20250429 (date) — Filing Date
- 20250626 (date) — Period of Report
- 2024-12-31 (date) — Fiscal Year End
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is used to solicit shareholder votes on important corporate matters, such as the election of directors and executive compensation.
When was this specific DEF 14A filing submitted by United Therapeutics Corp?
This DEF 14A filing was submitted on April 29, 2025.
What is the fiscal year end for United Therapeutics Corp?
The fiscal year end for United Therapeutics Corp is December 31.
What type of information is typically found in a DEF 14A filing?
DEF 14A filings typically include information on director nominees, executive compensation, corporate governance, and proposals to be voted on by shareholders.
Does this filing cover financial data for multiple years?
Yes, the filing references financial data for the fiscal years 2020 through 2024.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 29, 2025 regarding UNITED THERAPEUTICS Corp (UTHR).